Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Sónia A. Melo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-2291-4263; OpenAlex author ID A5060854639. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
35
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 4 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 17

  1. NK Cell Adoptive Transfer Suppresses Metastasis and Prolongs Survival in Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-9082655/v1↗
  2. A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. Co-author DOI 10.1186/s13046-025-03389-5↗
  3. Exosomes define a local and systemic communication network in healthy pancreas and pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41467-024-45753-7↗
  4. Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies. Co-author DOI 10.3389/fonc.2024.1466255↗
  5. SMC3 epigenetic silencing regulates Rab27a expression and drives pancreatic cancer progression. Last author DOI 10.1186/s12967-023-04448-1↗
  6. Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis. Co-author DOI 10.1016/j.dld.2021.10.012↗
  7. Author Correction: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/s41586-022-05062-9↗
  8. Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression. Last author DOI 10.1136/gutjnl-2021-324994↗
  9. Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities. Last author DOI 10.3748/wjg.v28.i31.4310↗
  10. Treatment optimization of locally advanced and metastatic pancreatic cancer (Review). Co-author DOI 10.3892/ijo.2021.5290↗
  11. Exosomes and the Future of Immunotherapy in Pancreatic Cancer. First author DOI 10.3390/ijms20030567↗
  12. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Last author DOI 10.3389/fendo.2018.00779↗
  13. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Co-author DOI 10.1038/nature22341↗
  14. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer. Co-author DOI 10.1080/15384047.2017.1281499↗
  15. Multiple antibodies identify glypican-1 associated with exosomes from pancreatic cancer cells and serum from patients with pancreatic cancer Co-author DOI 10.1101/145706↗
  16. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/nature14581↗
  17. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. First author DOI 10.1074/jbc.c113.532267↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Inês A. Batista · 6 shared papers, 2019–2026 · strength 0.99
  2. Bárbara Adem · 5 shared papers, 2022–2024 · strength 0.76
  3. Raghu Kalluri · 7 shared papers, 2014–2022 · strength 0.53
  4. Nuno Bastos · 3 shared papers, 2022–2024 · strength 0.52
  5. Carolina F. Ruivo · 4 shared papers, 2017–2024 · strength 0.50
  6. Pedro Moutinho-Ribeiro · 4 shared papers, 2018–2022 · strength 0.49
  7. Guilherme Macedo · 4 shared papers, 2018–2022 · strength 0.49
  8. Marilia L. Cravo · 2 shared papers, 2022–2026 · strength 0.35
  9. Christoph Kahlert · 4 shared papers, 2014–2022 · strength 0.29
  10. Celso Albuquerque Reis · 1 shared paper, 2024 · strength 0.26
  11. Rafaela Abrantes · 1 shared paper, 2024 · strength 0.26
  12. Juliana Calheiros · 1 shared paper, 2025 · strength 0.20
  13. Vincenzo Corbo · 1 shared paper, 2025 · strength 0.20
  14. Lucı́lia Saraiva · 1 shared paper, 2025 · strength 0.20
  15. Tao Wang · 1 shared paper, 2025 · strength 0.20
  16. Elena Fiorini · 1 shared paper, 2025 · strength 0.20
  17. Dieter Saur · 1 shared paper, 2024 · strength 0.20
  18. David R Piwnica-Worms · 2 shared papers, 2015–2022 · strength 0.17
  19. Nuh N. Rahbari · 2 shared papers, 2015–2022 · strength 0.17
  20. Christoph Reißfelder · 2 shared papers, 2015–2022 · strength 0.17
  21. Christian P. Pilarsky · 2 shared papers, 2015–2022 · strength 0.17
  22. Anabela Barros · 1 shared paper, 2021 · strength 0.14
  23. Hélder Mansinho · 1 shared paper, 2021 · strength 0.14
  24. Nuno Couto · 1 shared paper, 2021 · strength 0.14
  25. Sujuan Yang · 2 shared papers, 2017 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.